01846.HK
EuroEyes International Eye Clinic Limited
HKSE · Healthcare · Medical - Care Facilities · DE
HKD 2.35
−0.42%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 1.6B | 796.0M | 715.7M | 714.3M | 610.3M |
| Cost of Revenue | 970.2M | 471.7M | 429.1M | 378.8M | 339.4M |
| Gross Profit | 627.5M | 324.3M | 286.6M | 335.5M | 270.8M |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 469.2M | 209.5M | 185.8M | 96.0M | 77.9M |
| General & Admin Expense | 168.6M | 112.6M | 104.7M | 39.9M | 37.2M |
| Selling & Marketing Expense | 141.1M | 96.7M | 80.8M | 56.0M | 40.7M |
| Other Expenses | (12.0M) | 221.0K | (15.0M) | 46.0M | 60.1M |
| Total Operating Expenses | 457.2M | 209.7M | 170.8M | 142.0M | 138.0M |
| Cost and Expenses | 1.4B | 681.4M | 599.9M | 520.8M | 477.5M |
| Operating Income (EBIT) | 170.3M | 114.6M | 115.8M | 193.5M | 132.8M |
| Non-Operating | |||||
| Interest Income | 29.6M | 13.4M | 23.6M | 19.3M | 1.1M |
| Interest Expense | 25.5M | 11.5M | 15.8M | 14.1M | 10.7M |
| Net Interest Income | 4.0M | 1.9M | 7.8M | 5.2M | (9.6M) |
| Other Non-Op Income/Expense | (3.2M) | (12.2M) | 10.7M | (2.9M) | (3.8M) |
| Non-Operating Income (excl Interest) | 6.7M | (1.9M) | 11.1M | 15.6M | (3.3M) |
| EBT (Pre-Tax Income) | 167.1M | 102.4M | 126.5M | 190.6M | 129.0M |
| Income Tax Expense | 84.2M | 45.8M | 42.1M | 57.4M | 45.5M |
| Bottom Line | |||||
| Net Income | 79.0M | 54.5M | 82.3M | 131.2M | 89.5M |
| Earnings from Cont. Ops | 82.9M | 56.6M | 84.4M | 133.3M | 83.5M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 79.0M | 54.5M | 82.3M | 131.2M | 89.5M |
| Per Share | |||||
| Basic EPS | HK$0.25 | HK$0.17 | HK$0.25 | HK$0.40 | HK$0.27 |
| Diluted EPS | HK$0.25 | HK$0.17 | HK$0.25 | HK$0.40 | HK$0.27 |
| Revenue Per Share | HK$5.01 | HK$2.49 | HK$2.17 | HK$2.15 | HK$1.84 |
| Shares | |||||
| Basic Shares Outstanding | 318.8M | 319.8M | 330.3M | 332.2M | 331.9M |
| Diluted Shares Outstanding | 318.8M | 319.8M | 330.3M | 332.2M | 332.3M |
| Profitability Metrics | |||||
| EBITDA | 299.4M | 163.6M | 141.9M | 292.1M | 220.4M |
| D&A | 135.8M | 47.1M | 37.2M | 87.3M | 80.7M |
| EBIT | 163.6M | 116.5M | 104.7M | 204.8M | 139.7M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026